
What is your career and/or educational background?
I studied at The University of Edinburgh for a BSc (Hons) Biological Sciences (Immunology) between 2009-2013. Unsure of what I wanted to do, I enrolled in an MSc Immunology of Infectious Disease at the London School of Hygiene and Tropical Medicine which I completed in 2014. At this point I had an inkling that I wanted to work for the NHS in some capacity and so took an opportunity to work within clinical commissioning at Luton Clinical Commissioning Group (CCG). I worked to support joined up commissioning between Luton CCG and Luton Borough Council to meet the healthcare needs of the local population. After a year, I decided to enter back into the scientific world and applied for the NHS Scientist Training Programme (STP), gaining a place in Histocompatibility and Immunogenetics (H&I) at Leeds Transplant Immunology laboratory in 2015. I completed the STP programme in 2018, including a MSc Clinical Science (H&I) from the University of Manchester. I worked as a state registered H&I Clinical Scientist in Leeds for a further 6.5 years, before joining VH Bio in June 2025 as a Transplant Technical Sales Specialist.
Describe what your job entails.
My primary role is to contribute to the provision of responsive specialist technical support and educational programmes to customers using products within VH Bio’s transplant product portfolio, as well as supporting sales development of these products to new potential customers.
What are you most looking forward to in your new role?
I am looking forward to gaining the advanced technical troubleshooting skills and growing my in-depth specialist product knowledge which comes with the role. I am also excited to meet with and support H&I labs and their scientists across the UK with their transplant programmes and contribute to the rapidly progressing field of transplantation!
Connect with Victoria
Articles by Victoria
31st March 2026
From Antigens to Epitopes: Refining HLA-Antibody Risk Assessment The wide adoption of virtual crossmatching to assess donor/recipient immunological risk has necessitated a focus on HLA-antibody definition beyond the traditional antigenic-level. Increased access to allelic-level donor and recipient HLA-typing, in combination with tools enabling greater definition of HLA-antibody profiles, can aid in more nuanced immunological risk assessment with the aim of optimising graft and patient outcomes [1]. Of note, this is of particular importance to highly [...]
29th September 2025
See our photo gallery and read Victoria's play-by-play of the programme, presentations, and people at this year's BSHI Conference! For VH Bio, it all started the day before as we hosted our Pre-BSHI NGS Technologies workshop. Armed with cups of coffee [...]


